Faster global financial news!
Innovative drugs
-
As of 18:00 on October 26, 129 A-share pharmaceutical and biological companies have disclosed their third-quarter reports
As of 18:00 on October 26, 129 A-share pharmaceutical and biological companies have disclosed their third-quarter reports, and 15 companies have released their Q1-Q3 performance forecasts, with over 4
-
Hansoh Pharmaceutical inks up to $15B drug deal with Roche, China's innovative drug out-licensing hits $130B
Hong Kong-listed Hansoh Pharmaceutical Group announced a collaboration agreement with Swiss healthcare company F. Hoffmann-La Roche, potentially worth over $15 billion in development, regulatory appro
-
China's A-share market saw its three major indices open higher, with military and innovative drug sectors surging, and AI hardware showing a recovery.
On the morning of October 16, China's A-share market saw its three major indices open higher across the board, with the Shanghai Composite Index up 0.49%, the Shenzhen Component Index up 0.65%, and th
-
China aims for five innovative drugs with over $1 billion annual global sales by 2030
Beijing has set ambitious new five-year targets to boost its global presence, including at least five pharmaceutical products with annual global sales surpassing US$1 billion by 2030. Jefferies' head
-
HSBC Qianhai: China's pharmaceutical sector sees increasing divergence, with leading innovative drug companies embracing BD for a second growth curve.
HSBC Qianhai's latest research report indicates that China's pharmaceutical sector is undergoing a structural revaluation amid anti-corruption efforts and pressure to control medical insurance costs,
-
As of 18:00 on October 26, 129 A-share pharmaceutical and biological companies have disclosed their third-quarter reports
As of 18:00 on October 26, 129 A-share pharmaceutical and biological companies have disclosed their third-quarter reports, and 15 companies have released their Q1-Q3 performance forecasts, with over 4
-
Hansoh Pharmaceutical inks up to $15B drug deal with Roche, China's innovative drug out-licensing hits $130B
Hong Kong-listed Hansoh Pharmaceutical Group announced a collaboration agreement with Swiss healthcare company F. Hoffmann-La Roche, potentially worth over $15 billion in development, regulatory appro
-
China's A-share market saw its three major indices open higher, with military and innovative drug sectors surging, and AI hardware showing a recovery.
On the morning of October 16, China's A-share market saw its three major indices open higher across the board, with the Shanghai Composite Index up 0.49%, the Shenzhen Component Index up 0.65%, and th
-
China aims for five innovative drugs with over $1 billion annual global sales by 2030
Beijing has set ambitious new five-year targets to boost its global presence, including at least five pharmaceutical products with annual global sales surpassing US$1 billion by 2030. Jefferies' head
-
HSBC Qianhai: China's pharmaceutical sector sees increasing divergence, with leading innovative drug companies embracing BD for a second growth curve.
HSBC Qianhai's latest research report indicates that China's pharmaceutical sector is undergoing a structural revaluation amid anti-corruption efforts and pressure to control medical insurance costs,
- No data
Innovative drugs
24H Trending
-
1
ETH cross-exchange spread hits 1.11%
-
2
ZEC (Zcash) surged 6.23% in a short-term rally over the past 4 hours, currently trading at $878.990
-
3
Bloomberg: Collins says steady, gradual rate hikes appropriate to lower inflation
-
4
How is the ZZZ token? Which exchanges is the ZZZ token listed on?
-
5
On November 13, U.S. spot Bitcoin ETFs saw a net outflow of $185 million, while spot Ethereum ETFs recorded a net inflow of $2.36 million.
-
6
TechCrunch: Petition Calling for Jensen Huang to Return to Office Reaches Over 115k Signatures, Backed by Musk and Others
-
7
An Analysis of the Compliance Regulatory Mechanism and Security Assessment of Hong Kong Virtual Asset Trading Platforms
-
8
Al Jazeera Op-Ed Citing Negotiators: Abu Dhabi Russia-Ukraine-US Talks Difficult; Moscow Says Closer to Peace
-
9
CNBC: Berkshire Hathaway Closes at All-Time High for Fourth Consecutive Session, Class A Shares Up 19.1% Since Q4
-
10
Bitcoin Falls Below $69,000 as Ether Slides Under $2,000
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
